By
Trending Posts
Regeneron, Sanofi & Viz.ai: How Are These Industry…
May 20, 2025 In a bold strategic alliance, Regeneron and Sanofi have teamed up with AI healthcare innovator…
How RevolKa’s $1.7M Series A Extension Fuels AI-Driven…
Sendai, Japan – May 20, 2025 RevolKa Ltd., a fast-growing biotechnology company leveraging AI for protein engineering, has…
Foxconn and NVIDIA: How Can AI-Driven Robotics Address…
May 18, 2025 In response to the World Health Organization’s projection of a 4.5 million nurse shortage by…
Is Quantum AI the Future of RNA Drug…
Key Highlights: INDIANAPOLIS, IN & SAN DIEGO, CA – In a major signal of the industry’s growing confidence…
Johnson & Johnson MedTech and Qure.ai Partner to…
May 10, 2025 – IndiaJohnson & Johnson MedTech has announced a strategic collaboration with healthcare AI innovator Qure.ai…
Can Eli Lilly and Purdue University reshape pharmaceutical…
The initiative will focus on applying artificial intelligence, robotics, and data science to improve every stage of the…
AI-driven ALS therapy: How Eli Lilly is expanding…
Key highlights AI-powered discovery enters clinical stageEli Lilly and Company has entered into a licensing agreement with Alchemab…
How Are Eli Lilly & BigHat Biosciences Using…
Key highlights San Mateo, CA – BigHat Biosciences, a biotechnology company applying machine learning to antibody design and…
How Is Medtronic Transforming Stroke Care with Methinks…
Medtronic and Methinks AI Collaborate to Revolutionize Early Stroke Detection and Treatment Portage, Michigan – April 2, 2025…
Trending Posts
Latest Stories
Accelerating Drug Discovery with Artificial Intelligence: Strategic Insights from Pharma’s Biggest AI Alliances
Executive SummaryThe convergence of artificial intelligence (AI) and drug discovery is a strategic imperative. Pharmaceutical…
Is Merck’s WINREVAIR Set to Redefine First-Year PAH Treatment? Phase 3 HYPERION Results Show Over 70% Clinical Event Risk Reduction in Newly Diagnosed Patients
Key Takeaways:• Game-Changing Efficacy: WINREVAIR™ (sotatercept-csrk) cut clinical worsening risk in PAH by a statistically…
Can Sanofi’s Sarclisa-VRd Regimen, Backed by EMA’s CHMP, Redefine Frontline Standards in Transplant-Eligible Multiple Myeloma?
Key Highlights EMA’s CHMP Endorses Sarclisa-VRd for Frontline Multiple Myeloma in Transplant-Eligible AdultsOn June 23,…
Could Lilly’s Oral GLP-1 Orforglipron Revolutionize Type 2 Diabetes Treatment? Complete Phase 3 Results Show Compelling Efficacy and Safety on Par with Injectable GLP-1 Therapies
Key Highlights Orforglipron Delivers Clinically Meaningful Glycemic and Weight ImprovementsThe ACHIEVE-1 Phase 3 trial established…
Gallery
